Getting your player ready...
OSLO — A $225 million fund to provide low-price anti-malaria medicine was launched in the Norwegian capital Friday to fight a disease that kills 2,000 children a day.
New drug combinations have been developed to treat strains of malaria that have become resistant to the old remedies, but they cost 10 to 40 times more and are available to only 20 percent of those with the disease, according to a statement from the new body, the Affordable Medicines Facility for Malaria.
The program will cut the cost to between 20 and 50 cents per treatment, from $6 to $10, by negotiating price cuts with pharmaceutical companies and through subsidies from international donors.
